XML 43 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Organization and Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2018
Accounting Policies [Abstract]  
Schedule of Property and Equipment
Property and equipment are recorded at cost and depreciated using the straight-line method over their estimated useful lives as follows: 
Computer and office equipment
3 years
Furniture and fixtures
5-7 years
Laboratory equipment
7 years
Building asset under facility lease
25 years
Property and equipment consisted of the following:
 
December 31,
 
2018
 
2017
Computer equipment
$
577

 
$
529

Furniture and fixtures
312

 
354

Laboratory equipment
7,442

 
6,819

Office equipment
400

 
400

Building related to facility lease obligation
10,557

 
10,557

Leasehold improvements
1,168

 
1,000

Property and equipment, gross
20,456

 
19,659

Less: Accumulated depreciation and amortization
(4,588
)
 
(3,035
)
Total property and equipment, net
$
15,868

 
$
16,624

Summary of Anti-dilutive Securities Excluded from Calculation of Weighted Average Common Shares Outstanding
The following securities, presented on a common stock equivalent basis, have been excluded from the calculation of weighted average common shares outstanding for the years ended December 31, 2018 and 2017 because the effect is anti-dilutive due to the net loss reported in each of those periods. All share amounts presented in the table below represent the total number outstanding as of the end of each period. In addition, as described in Note 10—Share-Based Compensation, the Company’s board granted 1,000,000 SARs in the third quarter of 2018. These securities are subject to shareholder approval and therefore are not considered outstanding as of December 31, 2018; however, if such securities were to be approved by shareholders, their effect would be anti-dilutive. 
 
December 31,
 
2018
 
2017
Warrants to purchase common stock associated with January 2018 public offering (Note 9)
10,000,000

 

Stock options outstanding under the 2008 and 2016 Plans (Note 10)
1,671,666

 
1,399,484

Inducement options outstanding (Note 10)
100,500

 

ASU 2014-09 (Topic 606)  
New Accounting Pronouncements or Change in Accounting Principle [Line Items]  
Adoption of Revenue Recognition Standard Impacted Previously Reported Results
Adoption of the revenue recognition standard, which is described in detail in “Note 5—Revenue Recognition”, impacted previously reported results as follows:
Consolidated Statements of Operations and Comprehensive Loss
 
Year Ended December 31, 2017
 
As Reported
 
Adjustments
 
As Adjusted
License and collaboration revenue
$
1,765

 
$
506

 
$
2,271

Research and development services revenue
375

 

 
375

Total revenue
2,140

 
506

 
2,646

Operating expenses:
 
 
 
 
 
Research and development
25,212

 

 
25,212

General and administrative
13,113

 

 
13,113

Total operating expenses
38,325

 

 
38,325

Operating loss
(36,185
)
 
506

 
(35,679
)
Other expense, net
(942
)
 

 
(942
)
Net loss and comprehensive loss
$
(37,127
)
 
$
506

 
$
(36,621
)
Net loss per share, basic and diluted
$
(2.32
)
 
$
0.03

 
$
(2.29
)
Weighted-average common shares outstanding, basic and diluted
15,981,247

 

 
15,981,247

Consolidated Balance Sheets
 
December 31, 2017
 
As Reported
 
Adjustments
 
As Adjusted
Deferred revenue, current portion
$
2,164

 
$
467

 
$
2,631

Deferred revenue, net of current portion
6,919

 
(973
)
 
5,946

Accumulated deficit
(160,160
)
 
506

 
(159,654
)